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This study was aimed to examine the eﬀects of indole-3-carbinol (I3C) and β-phenylethyl isothiocyanate (PEITC), bioactive
components present in cruciferous vegetable, on the production of inﬂammatory mediators, including nitric oxide (NO), tumor
necrosis factor-α (TNF-α) and interleukin-10 (IL-10), in lipopolysaccharide- (LPS-) stimulated RAW 264.7 macrophages. Possible
mechanisms of the NO-inhibitory eﬀects were also explored. The results indicated that I3C and PEITC inhibited NO production,
and this suppression was associated with decreased production of TNF-α and IL-10 by activated macrophages. In addition, I3C
suppressedNOproductionevenaftertheinduciblenitricoxidesynthase(iNOS)proteinhadbeenproduced,butsuchaninhibitory
eﬀect was not observed in cells treated with PEITC. Furthermore, both compounds reduced the NO contents generated from an
NO donor in a cell-free condition, suggesting that the increased NO clearance may have contributed to the NO-inhibitory eﬀects.
In summary, both I3C and PEITC possessed antiinﬂammatory eﬀects by inhibiting the productions of NO, TNF-α, and IL-10,
although the NO-inhibitory eﬀects may have involved in diﬀerent mechanisms.
1.Introduction
Macrophages play important roles in a host’s immune
defense system during infection as well as in the pro-
cesses of disease development. Activation of macrophages
by stimuli, such as the bacterial endotoxin, lipopolysac-
charide (LPS), and viruses, increases the production of
numerous inﬂammatory mediators, including nitric oxide
(NO), prostaglandin E2 (PGE2), and various cytokines
[1]. NO is a small radical molecule that possesses many
physiological functions, being involved in vasorelaxation,
neurotransmission, immunoregulation, and inﬂammation.
NO is synthesized from the amino acid L-arginine by
nitric oxide synthase (NOS) in various cells and tissues.
Among isoforms identiﬁed, the inducible form of NOS
(iNOS) is mainly expressed in macrophages and lympho-
cytes, and is synthesized by stimulants such as bacterial
endotoxin lipopolysaccharide (LPS) and cytokines, includ-
ing interferon-γ (IFN-γ), interleukin-1 (IL-1), and tumor
necrosis factor-α (TNF-α)[ 2]. Low concentrations of NO
produced by iNOS are involved in antipathogenic and
antitumor responses of macrophages. However, prolonged
overproduction of NO and the dysregulated expressions of
cytokinesduringchronicinﬂammationhavebeenimplicated
in several pathological conditions, such as autoimmune
diseases and cancers [2–4]. Hence, agents that regulate the
production of cytokines and suppress the overproduction
of NO may possess protective roles in inﬂammation-related
diseases.
There is increasing interest in using natural products
to modulate immune responses and neutralize inﬂam-
matory processes because of their fewer side eﬀects and
lower cytotoxicities [5, 6]. Cruciferous vegetables, including
broccoli, cauliﬂower, cabbage, and mustard, are reported
to play protective roles in diﬀerent diseases. The high
contents of glucosinolates and glucosinolate derivatives,
including isothiocyanates and indoles, were implicated
as being responsible for the biological eﬀects of these2 Mediators of Inﬂammation
vegetables [7–9]. Both isothiocyanate and indole deriva-
tives, including phenylethyl isothiocyanate (PEITC), sul-
foraphane, and indole-3-carbinol (I3C), are reported to
suppress NO production by inhibiting inducible nitric
oxide synthase (iNOS) expression in activated RAW 264.7
macrophages [10–12]. Although sulforaphane and PEITC
were shown to decrease TNF-α production and interleukin-
1β (IL-1β) mRNA expression, respectively, in LPS-activated
macrophages [10, 11], there is little information on
the eﬀects of I3C on cytokine production. Besides, the
eﬀects of PEITC or I3C on these inﬂammatory medi-
ators are usually examined individually, not simultane-
ously, or compared under the same conditions. Because
the productions of NO and cytokines are closely asso-
ciated, this study attempted to examine and compare
the eﬀects of PEITC and I3C on the productions of
NO and cytokines, including the proinﬂammatory TNF-
α, and the antiinﬂammatory IL-10, in LPS-activated RAW
264.7 cells. To obtain further insights into the NO-
suppressive eﬀects of these compounds, indirect NOS
enzyme activities and in vitro NO clearance activities were
also investigated. Results from this study may increase
our understanding of how compounds from cruciferous
vegetable modulate immune functions, and the poten-
tial use of these compounds in inﬂammation-related
diseases.
2.MaterialsandMethods
2.1. Chemicals and Biochemicals. I3C, PEITC, LPS, sul-
fanilamide, N-(1-naphthyl)ethylenediamine dihydrochlo-
ride, and sodium nitrite were commercially obtained from
Sigma Chemical (St. Louis, MO). Absolute ethanol was
purchased from Merck (Darmstadt, Germany). Dulbecco’s
modiﬁed Eagle medium (DMEM) and fetal bovine serum
(FBS) were from GIBCO (Grand Island, NY). All other
laboratory chemicals were purchased from Sigma and USB
(Cleveland, OH).
2.2.CellCulture. Murinemonocyte-macrophageRAW264.7
cells were obtained from the Biosource Collection and
Research Center, Hsinchu, Taiwan (BCRC 60001). Cells were
grown as monolayers in DMEM supplemented with 10%
FBS at 37
◦C in an atmosphere of 95% air and 5% CO2.
I3C and PEITC were dissolved in absolute ethanol, and the
concentration of absolute ethanol added to the media never
exceeded 0.01% (v/v).
2.3. Assays for NO and Cytokine Production and Release.
Nitrite concentration in the culture medium was quan-
tiﬁed spectrophotometrically after its reaction with the
Griess reagent (a 1:1 mixture of 1% sulfanilamide/5%
H3PO4 and0.1%naphthylethylenediaminedihydrochloride)
[13]. The production and release of cytokines in the
culturemediumweredeterminedusingcommercialenzyme-
linked immunosorbent assay (ELISA) kits (Amersham Bio-
sciences, Buckinghamshire, UK) following the manufactur-
ers’ instructions.
2.4. In Vitro NO Clearance Activity. NO clearance activities
of these compounds were determined according to a method
modiﬁed from by Marcocci et al. [14]. Basically, I3C and
PEITC were incubated in an NO donor solution of sodium
nitroprusside (SNP) (10mM) at room temperature for 30
minutesinacell-freecondition,andthenitriteconcentration
in the reaction mixture was determined using the Griess
reagent.
2.5. Statistical Analysis. Values are expressed as the mean
± standard deviation (SD), and were analyzed using SAS
software versus 6.12 (SAS Institute, Cary, NC). One-way
analysis of variance (ANOVA) followed by Fisher’s least
signiﬁcant diﬀerence test and Student’s t-test was used
to determine statistical diﬀerences between groups. The
signiﬁcance of the mean diﬀerences was based on a P value
of <.05.
3. Results and Discussion
3.1. Eﬀects of I3C and PEITC on LPS-Stimulated NO Produc-
tion. Figure 1 shows that I3C and PEITC inhibited 52% to
77% and 22% to 89% of LPS-stimulated NO production,
respectively. Because no cytotoxic eﬀect was observed after
cells were treated with LPS in the presence of I3C or PEITC
for 24 hours, the NO-inhibitory eﬀects by I3C and PEITC
were not due to cytotoxicity. Comparing to the results
obtained from macrophages that were activated by LPS/
IFN-γ [12], greater NO-inhibitory potencies were observed
in LPS-activated macrophages, indicating that IFN-γ might
generate more complicated responses on NO production in
macrophages.
Although evidence demonstrated that the decreased NO
production by I3C and PEITC is mediated through the sup-
pressing iNOS protein expression in activated macrophages
[12, 15], other possibilities may exist. Because the expression
of iNOS may be also regulated at the posttranslation level
[16], iNOS enzyme activity was indirectly evaluated. After
being activated with LPS for diﬀerent periods of time,
macrophages were treated with I3C or PEITC for up to
24 hours, and the NO content in the culture medium was
examined. The results showed that LPS-stimulated NO pro-
duction was inhibited by I3C treatment regardless of the pre-
or cotreatment with LPS, although cotreated cells exhibited
a greater extent of inhibition (Figure 2(a)), suggesting that
I3C interfered with iNOS’s enzyme activity. PEITC, on the
other hand, showed a distinct pattern in LPS-treated cells,
where no inhibition was noted in 12-hour LPS-pretreated
cells, less inhibition was observed in 6-hour pretreated cells,
and the maximal NO suppression occurred in cotreated cells
(Figure 2(b)), indicating that PEITC had no impact on iNOS
enzyme activity once the protein was synthesized. NO is a
small molecule with free radical characteristics, so it readily
interacts with other compounds. Because I3C was reported
to be capable of acting as a scavenger of free radicals [17],
in vitro NO clearance activity of these compounds was also
examined. As shown in Figure 3, both I3C (50μM) and
PEITC (5μM) decreased the levels of NO generated fromMediators of Inﬂammation 3
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Figure 1: Eﬀects of I3C (a) and PEITC (b) on lipopolysaccharide-
(LPS-) induced NO released into the medium by RAW 264.7 cells.
CellsweretreatedwithLPS(330ng/mL)andvariousconcentrations
of I3C and PEITC for 24 hours. The nitrite contents in the medium
were then determined using the Griess reagent. Values represent the
mean ± SD from three measurements, and LPS group is regarded
as 100%. Data for the same parameter with diﬀerent letters (a–f)
signiﬁcantly diﬀer (P < .05).
the NO donor. Therefore, I3C and PEITC might directly
interact with NO, thus decreasing its availability. Blomhoﬀ
[18] suggested that cruciferous vegetables are dietary plants
richincompoundsthatcanreduceoxidativestress,including
reactive nitrogen species (RNS), which may be formed from
excess NO free radicals, and I3C was shown to serve as a
scavenger of free radicals and inhibit lipid peroxidation [17,
19].Furthermore,glutathioneS-transferase(GST),aphaseII
xenobiotic metabolism enzyme which can be induced by I3C
or PEITC, was indicated to be able to inactivate NO [20], so
I3CandPEITCmayalsoindirectlyeliminateNOthroughthe
induction of GST. Alternatively, LPS-induced macrophage
activation was reported to require the LPS receptor complex,
which plays essential roles in binding and in mediating
the response to LPS [21]. Therefore, binding interference
of I3C or PEITC with either LPS and/or the LPS receptor
complex cannot be ruled out. Nevertheless, PEITC did not
showanyimpactonNOproductionwhenmacrophageswere
pretreated with LPS for 12 hours (Figure 2(b)). A higher NO
concentration generated from the LPS-treated cells (18.31
± 0.60μM) comparing to the in vitro condition (8.96 ±
0.08μM) may explain the discrepancy, because the NO con-
centration was too high for PEITC to react without inhibited
iNOSactivity.Ontheotherhand,thebindingofintracellular
proteins by PEITC [22] may also decrease its bioavailability
on NO clearance. Taken together, diﬀerent mechanisms
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Figure 2: Eﬀects of I3C (a) and PEITC (b) on NO production in
lipopolysaccharide- (LPS-) pretreated with RAW 264.7 cells. Cells
werepretreatedwithLPS(330ng/mL)for0,6,or12hours,followed
by the addition of various concentrations of I3C and PEITC for up
to24hours.Thenitritecontentinthemediumwasthendetermined
by the Griess reagent. Values represent the mean ± SD from three
measurements. An asterisk (∗) indicates a signiﬁcant diﬀerence
from the corresponding LPS control group (P < .05).
may be involved in the NO-inhibitory eﬀects of I3C and
PEITC. I3C may act through decreasing iNOS expression,
interfering with iNOS enzyme activity, and directly trapping
NO to decrease NO availability, whereas PEITC mainly acts
through decreasing iNOS expression and directly interacting
with NO. Nevertheless, the molecular mechanisms of NO’s
inhibitory eﬀects against these derivatives require further
investigation.
3.2. Eﬀects of I3C and PEITC on the Production of Cytokines.
TheproductionofNOcanberegulatedbyvariouscytokines,
so the release of the proinﬂammatory TNF-α and the anti-
inﬂammatory cytokine, IL-10, was determined. As shown
in Figure 4, LPS signiﬁcantly enhanced the productions of
TNF-α and IL-10 by RAW 264.7 cells, and high concen-
trations of I3C and PEITC suppressed such enhancements
of both TNF-α and IL-10. The expression of iNOS can be4 Mediators of Inﬂammation
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Figure 3: Eﬀects of I3C and PEITC on in vitro NO clearance
activity. I3C (50μM) and PEITC (5μM) were incubated in a 10mM
sodium nitroprusside (SNP) solution for 30 minutes, and the
nitrite content in the reaction mixture was then determined using
the Griess reagent. Values represent the mean ± SD from three
measurements. An asterisk (∗) indicates a signiﬁcant diﬀerence
from the control group (P < .05).
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Figure 4: Eﬀects of I3C (a) and PEITC (b) on lipopolysaccharide-
(LPS-) activated cytokines released into the medium by RAW
264.7 cells. Cells were cotreated with LPS (330ng/mL) and various
concentrations of I3C and PEITC for 24 hours. The levels of
tumor necrosis factor-α (TNF-α) and interleukin-10 (IL-10) in
the medium were then determined using commercial ELISA kits.
Values represent the mean ± SD from three measurements. Data
in the same cytokine group with diﬀerent letters signiﬁcantly diﬀer
(P < .05).
induced by proinﬂammatory cytokines, such as TNF-α [23],
and inhibited by antiinﬂammatory cytokines, including IL-
10 [24]. It is reasonable to assume that the NO-inhibitory
eﬀects of these compounds may occur through suppressed
production of TNF-α or through increased production of
IL-10. Nonetheless, both TNF-α and IL-10 were signiﬁcantly
inhibited by high concentrations of I3C and PEITC in LPS-
stimulated macrophages, suggesting that IL-10 might not
playacrucialroleinI3C-andPEITC-inducedNOinhibition.
Because NO production may be regulated by a variety of
mechanisms as discussed, whereas TNF-α and IL-10 inhi-
bition may rely on suppression of gene expression, that is,
via NF-κB signaling pathway, the inhibitory eﬀects on TNF-
α a n dI L - 1 0p r o d u c t i o nb yI 3 Ca n dP E I T Ca r en o ta sp o t e n t
as that of NO production. On the other hand, a variety
of cytokines can be released after treatment with LPS, and
are mutually regulated; hence other cytokines, in addition
to TNF-α and IL-10, may act additively or synergistically
to aﬀect NO production. Furthermore, cytokines not only
modulate NO production, but NO may also modulate the
secretion of cytokines. NO was shown to modulate the
production of IL-2 and IFN-γ b yTc e l l s[ 23]a sw e l la sT N F -
α and IL-1β in activated alveolar macrophages [25], and this
may partially explain the eﬀects of I3C and PEITC on the
production of cytokines. Finally, diﬀerent studies indicated
that the expression of IL-10 in cultured macrophage might
not reﬂect what is observed in animals [26, 27]. For
example, an immunomodulator, SR31747A, downregulates
both NO and IL-10 expressions in LPS-activated RAW 264.7
macrophages, but it enhances IL-10 production in a murine
m o d e lo fs e p s i s[ 27]. Thus, the results obtained from this
study are informative, but require further investigation.
In conclusion, I3C and PEITC possess antiinﬂammatory
eﬀects by inhibiting the productions of NO, TNF-α,a n dI L -
10 in LPS-stimulated macrophages. NO’s inhibitory eﬀecton
I3C,inaddition todecreasingtheexpressionofiNOS,mayat
leastpartlybethroughinterferingwithiNOSenzymeactivity
as well as direct NO clearance activity, whereas PEITC may
act through its direct NO clearance activity but not interfere
with iNOS enzyme activity.
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